Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
FDA Approves XEOMIN® (incobotulinumtoxinA) for Adult Patients with Sialorrhea
Wednesday, July 04, 2018Merz North America announced today that the US Food and Drug Administration FDA has approved the supplemental Biologics License Application sBLA for XEOMIN incobotulinumtoxinA for the treatment of chronic sialorrhea or excessive drooling in adult pat...
FDA Approves ARISTADA INITIO™ for the Initiation of ARISTADA® for Schizophrenia
Tuesday, July 03, 2018Alkermes plc today announced that the US Food and Drug Administration FDA has approved ARISTADA INITIO aripiprazole lauroxil for the initiation of ARISTADA aripiprazole lauroxil a longacting injectable atypical antipsychotic for the treatment of schi...
UCB Announces Approval of NEUPRO® in China to Treat Parkinson's Disease
Tuesday, July 03, 2018Belgiumbased global biopharmaceutical company UCB today announced it has received an Import Drug License IDL from the China Food and Drug Administration CFDA creating a pathway to make the companys hour continuous delivery transdermal rotigotine patc...
Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement for Symjepi
Monday, July 02, 2018Adamis Pharmaceuticals Corporation announced today that it has entered into an exclusive distribution and commercialization agreement with Sandoz Inc Sandoz a division of the Novartis Group to commercialize Adamis Symjepi product for the emergency tr...
Vyxeos™ Receives Positive CHMP Opinion for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia
Saturday, June 30, 2018Jazz Pharmaceuticals plc today announced that the European Medicines Agencys Committee for Medicinal Products for Human Use CHMP issued a positive opinion recommending marketing authorisation of Vyxeos mg mg powder for concentrate for solution for i...
OWC Pharmaceutical Research Corp. Completes First Part of Cannabis-Based Ointment Safety Study
Saturday, June 30, 2018OWC Pharmaceutical Research Corp a developer of cannabinoidbased therapies targeting a variety of different medical conditions and disorders yesterday announced a successful completion of the first part of its Phase I placebo controlled maximal dose...
RedHill Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi
Friday, June 29, 2018RedHill Biopharma Ltd a speciality company primarily focused on late clinicalstage development and commercialization of proprietary drugs for gastrointestinal GI diseases today announced that it has entered into a copromotion agreement with Napo Phar...
Novaliq’s NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand
Friday, June 29, 2018Novaliq GmbH a specialty pharmaceutical company with the first waterfree technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology announced that NovaTears a novel topical treatment of dry eye disease DED...
NucleoBio Concludes Preliminary Tests For New Drug to Treat Aggressive Prostate Cancer
Thursday, June 28, 2018In the quest to develop a drug to effectively treat aggressive prostate cancer NucleoBio Inc has demonstrated efficacy for its newest product Prostreat Prostreat outperforms commercially available medications in inhibiting the growth and spread of th...
Purdue Pharma L.P. Announces Successful Completion of First-in-Human Study for Oncology Therapy Candidate Tinostamustine
Thursday, June 28, 2018Purdue Pharma LP today announced successful completion of a firstinhuman Phase dose escalation study of tinostamustine in patients with relapsed or refractory hematological malignancies for which there are no available therapies The study evaluated...
